ROIV News and Press, Roivant Sciences Ltd. From 04/11/23

2023-04-11 14:35:18 ET On Tuesday, a U.S. appeals court sided with Moderna ( NASDAQ: MRNA ) in a years-long patent dispute between the biotech and Arbutus ( NASDAQ: ABUS ) over messenger-RNA-based COVID vaccine technology. A three-judge panel at the U.S. Court of Appeals...

2023-04-04 10:34:48 ET After straight sessions of gains, the shares of Pfizer ( NYSE: PFE ) and BioNTech ( NASDAQ: BNTX ) dropped Tuesday after Arbutus Biopharma ( NASDAQ: ABUS ) sued the COVID-19 vaccine makers over infringement of its patents related to mRNA vaccin...

Clinical trial intelligence platform hits key commercial milestones, expands leadership team Lokavant, the clinical trial intelligence platform company, has achieved significant business milestones within three months of the company’s $21 million Series A funding announcement...

Lokavant, the clinical trial intelligence platform company, announces strategic new hires to drive its mission to make clinical trials smarter. Lokavant, launched in 2020, has hired Andrew (AJ) Mills as executive vice president of sales; Doug Weatherhead as vice president of marketing; an...

2023-03-28 10:30:35 ET Covant Therapeutics, a Boston-based drug discovery company operating under Roivant Sciences ( NASDAQ: ROIV ), announced a global licensing agreement with German pharma Boehringer Ingelheim on Tuesday to jointly develop cancer immunotherapies. Per the...

BOSTON, March 28, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement with Boehringer Ingelheim covering Covant’s ADAR1 program. The companies jointly aim to deve...

2023-03-23 14:17:31 ET Shares of biotech firm Roivant Sciences ( NASDAQ: ROIV ) lost ~6% on Thursday to reach the lowest level since December after SoftBank Vision Fund, one of its major institutional investors, sold $96M worth of company shares. SVF, the flagship inve...

2023-03-23 08:08:44 ET Summary Halvorsen's 13F portfolio value decreased from $21.66B to ~$19.98B this quarter. The number of positions decreased from 88 to 53. Viking Global increased Amazon and UnitedHealth while decreasing General Electric, Meta Platforms, and Boston Scientific...

2023-03-21 12:06:21 ET Shares of Roivant Sciences (NASDAQ: ROIV) were down 13.26% in mid-morning trading on Tuesday. The biotech company, which specializes in developing immuno-dermatology therapies, had been riding a rise in share price that occurred after it announced positive...

2023-03-16 17:24:42 ET Gainers: Hub Cyber Security ( HUBC ) +6% . Altimmune ( ALT ) +5% . Hawaiian Holdings ( HA ) +4% . MacroGenics ( MGNX ) +3% . PENN Entertainment ( PENN ) +3% . Losers: Sarepta Therapeutics ( NASDAQ...